MB
NVO

MidFirst Bank’s Novo Nordisk NVO Stock Holding History

MidFirst Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6K Hold
241
– – ﹤0.01% 508
2026
Q1 		$8.86K Sell
241
-7,251
-97% -$344K ﹤0.01% 531
2025
Q4 		$381K Buy
+7,492
New +$383K 0.03% 239

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MidFirst Bank's NVO Position: Q2 2026 in Review

MidFirst Bank held its Novo Nordisk (NVO) position steady in Q2 2026 at 241 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

MidFirst Bank first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $381K in Q4 2025. 1,138 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • MidFirst Bank held 241 shares of Novo Nordisk worth $11.6K as of Q2 2026.
  • MidFirst Bank left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #508 holding.
  • MidFirst Bank first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • MidFirst Bank's Novo Nordisk position peaked at $381K in Q4 2025.
  • 1,138 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.